These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27809695)

  • 21. Association and linkage studies of the 20q11.2 region (GRD-2 locus) with Graves' disease in the Tunisian population.
    Makni K; Hadj Kacem H; Rebaï A; Abid M; Ayadi H
    Ann Hum Biol; 2007; 34(5):566-72. PubMed ID: 17786592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Novel Environmental Substances Relevant to Pediatric Graves' Disease.
    Xia Q; Liu J; Xu X; Gu W; Gu K; Chen X; Xie R; Zhang D; Wu H; Sun H; Wang F; Chen L; Chen T
    Front Endocrinol (Lausanne); 2021; 12():691326. PubMed ID: 34248849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arg25Pro (c.915G>C) polymorphism of transforming growth factor β1 gene increases the risk of developing Graves' disease.
    Doğru-Abbasoğlu S; Vural P; Baki M; Özderya A; Karadağ B; Uysal M
    Int Immunopharmacol; 2014 Jun; 20(2):366-9. PubMed ID: 24742542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linkage analysis of candidate genes in autoimmune thyroid disease. II. Selected gender-related genes and the X-chromosome. International Consortium for the Genetics of Autoimmune Thyroid Disease.
    Barbesino G; Tomer Y; Concepcion ES; Davies TF; Greenberg DA
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3290-5. PubMed ID: 9745443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
    Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone hypoacetylation and increased histone deacetylases in peripheral blood mononuclear cells from patients with Graves' disease.
    Yan N; Zhou JZ; Zhang JA; Cai T; Zhang W; Wang Y; Muhali FS; Guan L; Song RH
    Mol Cell Endocrinol; 2015 Oct; 414():143-7. PubMed ID: 26116233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression Profile of Human Fc Receptor-Like 1, 2, and 4 Molecules in Peripheral Blood Mononuclear Cells of Patients with Hashimoto's Thyroiditis and Graves' Disease.
    Rostamzadeh D; Dabbaghmanesh MH; Shabani M; Hosseini A; Amirghofran Z
    Horm Metab Res; 2015 Aug; 47(9):693-8. PubMed ID: 25738996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study.
    Kurylowicz A; Ramos-Lopez E; Bednarczuk T; Badenhoop K
    Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):329-35. PubMed ID: 16868893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism of IL37 gene as a protective factor for autoimmune thyroid disease.
    Yan N; Meng S; Song RH; Qin Q; Wang X; Yao Q; Jiang Y; Jiang W; Shi L; Xu J; Zhang J
    J Mol Endocrinol; 2015 Dec; 55(3):209-18. PubMed ID: 26373794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic susceptibility to autoimmune thyroid diseases in a Chinese Han population: Role of vitamin D receptor gene polymorphisms.
    Meng S; He ST; Jiang WJ; Xiao L; Li DF; Xu J; Shi XH; Zhang JA
    Ann Endocrinol (Paris); 2015 Dec; 76(6):684-9. PubMed ID: 26593863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease.
    Tomer Y; Concepcion E; Greenberg DA
    Thyroid; 2002 Dec; 12(12):1129-35. PubMed ID: 12593727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Weighted Genetic Risk Score Using Known Susceptibility Variants to Predict Graves Disease Risk.
    Ma YR; Zhao SX; Li L; Sun F; Ye XP; Yuan FF; Jiang D; Zhou Z; Zhang QY; Wan YY; Zhang GY; Wu J; Zhang RJ; Fang Y; Song HD
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2121-2130. PubMed ID: 30649410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pooled genome wide association detects association upstream of FCRL3 with Graves' disease.
    Khong JJ; Burdon KP; Lu Y; Laurie K; Leonardos L; Baird PN; Sahebjada S; Walsh JP; Gajdatsy A; Ebeling PR; Hamblin PS; Wong R; Forehan SP; Fourlanos S; Roberts AP; Doogue M; Selva D; Montgomery GW; Macgregor S; Craig JE
    BMC Genomics; 2016 Nov; 17(1):939. PubMed ID: 27863461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased expression of FcγRII in active Graves' disease patients.
    Lu X; Peng S; Wang X; Shan Z; Teng W
    J Clin Lab Anal; 2019 Jul; 33(6):e22904. PubMed ID: 31033004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of FcGRIIa with Graves' disease: a potential role for dysregulated autoantibody clearance in disease onset/progression.
    Yesmin K; Hargreaves C; Newby PR; Brand OJ; Heward JM; Franklyn JA; Gough SC; Simmonds MJ
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):119-25. PubMed ID: 20148910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
    Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
    Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease.
    Jazdzewski K; Bednarczuk T; Stepnowska M; Liyanarachchi S; Suchecka-Rachon K; Limon J; Narkiewicz K
    Int J Mol Med; 2007 Jan; 19(1):181-6. PubMed ID: 17143563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
    Aydın AF; Develi-İş S; Doğru-Abbasoğlu S; Vural P; Ozderya A; Karadağ B; Uysal M
    Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of association of IRF5 gene polymorphisms with autoimmune thyroid disease: a case-control study. IRF5 gene and AITD.
    Muhali FS; Zhou-jiao Z; Wang Y; Wang Q; Shi XH; Jiang WJ; Xiao L; Li DF; He ST; Xu J; Zhang JA
    Ann Endocrinol (Paris); 2014 Feb; 75(1):19-24. PubMed ID: 24582590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.